ANSER – An Algorithm for Neonatal Seizure Recognition from University College Cork June 2016 front page preview

ANSER – An Algorithm for Neonatal Seizure Recognition from University College Cork June 2016

Clinicians caring for neonates affected by seizures are poorly supported by specialist neurophysiology, especially out-of-hours, and there is an urgent unmet need for an intelligent cot-side seizure support tool. The ANS...

pdf 198.1KB

OcularColl – A thin-film, collagen-based scaffold for ocular repair. Licensing Opportunity from RCSI April 2016 front page preview

OcularColl – A thin-film, collagen-based scaffold for ocular repair. Licensing Opportunity from RCSI April 2016

Ocular surface disorders (OSDs) represent a range of specific conditions that often result in persistent epithelial defects of the cornea or damage to the conjunctiva. There are at least 25 million cases of OSDs in the U...

pdf 476.4KB

A Novel Method of Treating or Preventing Sepsis. Licensing Opportunity from RCSI April 2016 front page preview

A Novel Method of Treating or Preventing Sepsis. Licensing Opportunity from RCSI April 2016

Sepsis is a major challenge in the intensive care unit, where it is one of the leading causes of death. It arises unpredictability and can progress rapidly. Staphylococcus aureus and Escherichia coli are among the most c...

pdf 170.6KB

Doping of Germanium Surfaces - Licensing Opportunity from UCC April 2016 front page preview

Doping of Germanium Surfaces - Licensing Opportunity from UCC April 2016

The fundamental component of CMOS device technology is a doped or extrinsic semiconductor. Doping is a process whereby impurities are introduced into the crystal lattice of the semiconductor, creating charge carriers tha...

pdf 673.3KB

Bioblockers - Antifungal Biofilm Disruptors for Medical Devices - Licensing Opportunity from UCC April 2016 front page preview

Bioblockers - Antifungal Biofilm Disruptors for Medical Devices - Licensing Opportunity from UCC April 2016

Fungal infection can cause serious illness, especially in patients with compromised immune systems. UCC scientists have identified potent drug-like compounds capable of disrupting biofilm formation and growth; in particu...

pdf 148.3KB